KUALA LUMPUR: The Health Ministry’s Pharmaceutical Services Division has, today, revoked Hovid Bhd’s manufacturing licences. Hovid then announced a recall for Ternolol manufactured under batch number BG04645, bearing manufacturing date April 2016, for the Malaysian market. This was because the boxes labelling the tablets as Ternolol 50 on the outer packaging, contained blisters which were labelled as Ternolol Tab 100mg. Following corrective actions as required by the Health Ministry, Hovid said it will invite the NPRA to audit its facilities again by the end of January 2017. Hovid said the re-issuance of its manufacturing licences will be subjected to the outcome of the audit.

Source: New Strait Times January 09, 2017 13:20 UTC